104 related articles for article (PubMed ID: 22426389)
1. Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury.
Repici M; Chen X; Morel MP; Doulazmi M; Sclip A; Cannaya V; Veglianese P; Kraftsik R; Mariani J; Borsello T; Dusart I
Neurobiol Dis; 2012 Jun; 46(3):710-21. PubMed ID: 22426389
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of spinal c-Jun-NH2-terminal kinase (JNK) improves locomotor activity of spinal cord injured rats.
Martini AC; Forner S; Koepp J; Rae GA
Neurosci Lett; 2016 May; 621():54-61. PubMed ID: 27080425
[TBL] [Abstract][Full Text] [Related]
3. Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.
Repici M; Centeno C; Tomasi S; Forloni G; Bonny C; Vercelli A; Borsello T
Neuroscience; 2007 Nov; 150(1):40-9. PubMed ID: 17900813
[TBL] [Abstract][Full Text] [Related]
4. Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia.
Ginet V; Puyal J; Magnin G; Clarke PG; Truttmann AC
J Neurochem; 2009 Feb; 108(3):552-62. PubMed ID: 19046406
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury.
Citron BA; Arnold PM; Haynes NG; Ameenuddin S; Farooque M; Santacruz K; Festoff BW
Spine (Phila Pa 1976); 2008 Oct; 33(21):2269-77. PubMed ID: 18827691
[TBL] [Abstract][Full Text] [Related]
6. Blockade of IL-6 signaling by MR16-1 inhibits reduction of docosahexaenoic acid-containing phosphatidylcholine levels in a mouse model of spinal cord injury.
Arima H; Hanada M; Hayasaka T; Masaki N; Omura T; Xu D; Hasegawa T; Togawa D; Yamato Y; Kobayashi S; Yasuda T; Matsuyama Y; Setou M
Neuroscience; 2014 Jun; 269():1-10. PubMed ID: 24657456
[TBL] [Abstract][Full Text] [Related]
7. JNK activation contributes to DP5 induction and apoptosis following traumatic spinal cord injury.
Yin KJ; Kim GM; Lee JM; He YY; Xu J; Hsu CY
Neurobiol Dis; 2005 Dec; 20(3):881-9. PubMed ID: 16005241
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.
Nijboer CH; Bonestroo HJ; Zijlstra J; Kavelaars A; Heijnen CJ
Neurobiol Dis; 2013 Jun; 54():432-44. PubMed ID: 23376684
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury.
Gao K; Shen Z; Yuan Y; Han D; Song C; Guo Y; Mei X
J Neurochem; 2016 Jul; 138(1):139-49. PubMed ID: 26443048
[TBL] [Abstract][Full Text] [Related]
10. A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI.
Iannotti CA; Clark M; Horn KP; van Rooijen N; Silver J; Steinmetz MP
Exp Neurol; 2011 Jul; 230(1):3-15. PubMed ID: 20338167
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.
Nijboer CH; van der Kooij MA; van Bel F; Ohl F; Heijnen CJ; Kavelaars A
Brain Behav Immun; 2010 Jul; 24(5):812-21. PubMed ID: 19766183
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.
Noble LJ; Donovan F; Igarashi T; Goussev S; Werb Z
J Neurosci; 2002 Sep; 22(17):7526-35. PubMed ID: 12196576
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects and impact on caspase-12 expression of tauroursodeoxycholic acid after acute spinal cord injury in rats.
Dong Y; Miao L; Hei L; Lin L; Ding H
Int J Clin Exp Pathol; 2015; 8(12):15871-8. PubMed ID: 26884858
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung.
Wu S; Kasisomayajula K; Peng J; Bancalari E
Pediatr Res; 2009 Apr; 65(4):381-6. PubMed ID: 19127219
[TBL] [Abstract][Full Text] [Related]
16. Nicotine attenuates morphological deficits in a contusion model of spinal cord injury.
Ravikumar R; Fugaccia I; Scheff SW; Geddes JW; Srinivasan C; Toborek M
J Neurotrauma; 2005 Feb; 22(2):240-51. PubMed ID: 15716630
[TBL] [Abstract][Full Text] [Related]
17. Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury.
Reigada D; Nieto-Díaz M; Navarro-Ruiz R; Caballero-López MJ; Del Águila A; Muñoz-Galdeano T; Maza RM
Neuroscience; 2015 Aug; 300():404-17. PubMed ID: 26004679
[TBL] [Abstract][Full Text] [Related]
18. Tegaserod, a small compound mimetic of polysialic acid, promotes functional recovery after spinal cord injury in mice.
Pan HC; Shen YQ; Loers G; Jakovcevski I; Schachner M
Neuroscience; 2014 Sep; 277():356-66. PubMed ID: 25014876
[TBL] [Abstract][Full Text] [Related]
19. Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury.
Lord-Fontaine S; Yang F; Diep Q; Dergham P; Munzer S; Tremblay P; McKerracher L
J Neurotrauma; 2008 Nov; 25(11):1309-22. PubMed ID: 19061375
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.
Cheng X; Zheng Y; Bu P; Qi X; Fan C; Li F; Kim DH; Cao Q
Exp Neurol; 2018 Jan; 299(Pt A):97-108. PubMed ID: 29056364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
